GOAL/ACTIVITY OVERVIEW
During this interactive and engaging activity, we will focus on addressing the role of omega-3 fatty acids in treating patients with or at high risk of atherosclerotic cardiovascular disease (ASCVD) using the most recent evidence and guideline recommendations.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, learners should be better able to:
-Describe the spectrum of large-scale omega-3 fatty acids on ASCVD outcomes trials
-Recognize the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
-Review information on clinical utility of adjuncts to statin therapy to improve management of patients with or at high risk of ASCVD events
TARGET AUDIENCE
This activity is designed to meet the educational needs of retail, hospital and managed care pharmacists.
Postgraduate Healthcare Education, LLC ("PHE") provides Power-Pak C.E.® educational programs for the broad spectrum of healthcare professions. Professional medical and pharmaceutical education constitutes PHE's core activity. PHE continues to successfully produce continuing education programs for all professional healthcare disciplines including pharmacists, pharmacy technicians, physicians, nurses, physician assistants, and nurse practitioners.
